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Abstract
Background: With long delays observed between sampling and availability of results, the usefulness of blood cultures in the
context of emergency infectious diseases has recently been questioned. Among methods that allow quicker bacterial
identification from growing colonies, matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass
spectrometry was demonstrated to accurately identify bacteria routinely isolated in a clinical biology laboratory. In order
to speed up the identification process, in the present work we attempted bacterial identification directly from blood culture
bottles detected positive by the automate.
Methodology/Principal Findings: We prospectively analysed routine MALDI-TOF identification of bacteria detected in
blood culture by two different protocols involving successive centrifugations and then lysis by trifluoroacetic acid or formic
acid. Of the 562 blood culture broths detected as positive by the automate and containing one bacterial species, 370 (66%)
were correctly identified. Changing the protocol from trifluoroacetic acid to formic acid improved identification of
Staphylococci, and overall correct identification increased from 59% to 76%. Lack of identification was observed mostly with
viridans streptococci, and only one false positive was observed. In the 22 positive blood culture broths that contained two
or more different species, only one of the species was identified in 18 samples, no species were identified in two samples
and false species identifications were obtained in two cases. The positive predictive value of bacterial identification using
this procedure was 99.2%.
Conclusions/Significance: MALDI-TOF MS is an efficient method for direct routine identification of bacterial isolates in
blood culture, with the exception of polymicrobial samples and viridans streptococci. It may replace routine identification
performed on colonies, provided improvement for the specificity of blood culture broths growing viridans streptococci is
obtained in the near future.
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Introduction
Currently, blood culture is likely the most significant specimen
type used for the diagnosis of bacterial infections, especially for
bloodstream infections. Automates perform continuous monitoring
of bacterial growth, which ensures quick reports to the physicians.
When a blood culture bottle is identified as growing bacteria the
automate, presumptive identification is based on Gram staining,
which allows classification of bacteria as eithercocci orbacilli and as
Gram-positive or Gram-negative. This information is given to
clinicians in order to adapt presumptive antibiotic therapy.
Detection of particular organisms is sometimes indicative of an
aetiology, i.e., all blood cultures positive for Gram-positive cocci in
chainswillorientdiagnosistowardstreptococcalendocarditis.Blood
culture medium would then be subcultured on agar plates in order
to obtain bacteria colonies that would be subjected to identification.
However, conventional identification is based on time-consuming
procedures that hamper proper management of patients with
respect to antibiotic and supportive treatments. Routine bacterial
identification is based on phenotypic tests, including Gram staining,
culture and growth characteristics and biochemical patterns.
Complete identification is routinely achieved within two days, but
may be longer for fastidious or atypical organisms. As this delay
between blood culture sampling and definitive identification of the
organism responsible for the bacteremiaand antibiotic susceptibility
testingislong,the usefulnessofsamplingbloodculturesatadmission
in emergency departments has been recently questioned [1–3].
Many improvements have been proposed to speed up the process of
detection and identification. In fact, the most rapid detection
systems based on direct detection of the most commonly
encountered bacteria in blood by real-time PCR are currently
being evaluated, but they do allow for evaluation of antibiotic
susceptibility [4,5]. The other systems are based on quick
identification of bacteria that have grown in blood culture bottles.
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procedures have reduced these delays. The most recent generation
of automates can detect even small bacterial growth [6–8]. When
growth is detected by the automate, it is possible to perform direct
identification of bacteria by molecular biology, such as universal
amplification and sequencing [9], nucleic acid-based fluorescence
hybridisation probes, such as FISH [10–12], DNA microarrays [13]
ormoleculardetectionamplification and specificprobes[14]. These
lastsystemsareusuallynot openandonlyallow detectionofone ora
few specific targets; however, they may provide no information
about presumptive antibiotic susceptibility (i.e., detection of MRSA)
[15,16]. These procedures are efficient but are expensive and/or
require high qualifications of bacteriology technicians. The same
procedures may be used on isolated colonies or even less complex
systems for defined microorganisms, such as the use of monoclonal
or polyclonal specificantibodies, whichare currently used for agents
commonly encountered in bacteremia, such as Staphylococcus aureus
or Streptococcus pneumoniae [17,18]. Among the most recent
procedures for rapid identification, bacterial identification based
on peptide spectra obtained by matrix-assisted laser desorption
ionisationtime-of-flight(MALDI-TOF)massspectrometryhasbeen
proposed and recently was successfully used for routine identifica-
tion of bacterial colonies in a university 4000-bed hospital [19].
Identification is quick; bacterial identification is obtained on the day
the bacterial colonies grow on subculture and thus the result is
obtained approximately one day earlier than with the conventional
procedure. As positive blood cultures represent a suspension of
bacteria and blood cells, we thought to separate bacteria and then
subject them to MALDI-TOF mass spectrometry. In the present
work, we evaluated the performance of MALDI-TOF mass
spectrometry for direct identification of bacteria in blood culture
bottles detected as positive by the automate.
Materials and Methods
Blood Culture System and Identification of Isolates
Our laboratory is equipped with Bactec 9240 automates, and
blood samples were taken in Bactec Plus aerobic and Lytic 10
anaerobic blood culture bottles and processed in the automate
according to the manufacturer’s recommendations. When a blood
culture bottle was detected as positive, the blood culture broth was
deposited on a glass slide to be subjected to Gram staining and was
subcultured onto Chocolat polyvitex and Columbia sheep blood
agar (Biomerieux, Marcy l’Etoile France) under aerobic and
anaerobic atmospheres. Study began by using protocol 1 which
was modified as protocol 2 in the second part of the study. All
positive blood culture bottles (one bottle per patient in the case of
several bottles are positive for the same patient during protocol 1)
were prospectively included over eight months. During the period
of protocol 1, the isolates were recovered after subculture, semi-
automated Gram staining (Aerospray Wiescor apparatus, Elitech,
Signes, France) and determination of catalase and oxidase
activities. Isolates were inoculated into the appropriate VITEK
identification strip using the VITEK 2 apparatus (BioMe ´rieux) or
API ANA identification strip for anaerobes (BioMe ´rieux).
Comparison using MALDI-TOF mass spectrometry on colonies
was performed as described by Seng et al. [19]. During the period
of protocol 2, isolates were identified by MALDI-TOF mass
spectrometry only. As for direct identification using MALDI-TOF
mass spectrometry directly on blood culture bottles samples were
anonymized and results obtained by using the protocol presented
herein not transmitted to clinicians in charge of patients, we did
not ask for informed consent of patients. This process was
submitted and approved by the Comite d’Ethique de l’IFR48.
Preparation of Samples for Mass Spectrometry
Protocol 1. Positive blood culture broth (1 ml) was
centrifuged at 500 rpm for 15 minutes in order to remove red
blood cells. The supernatant was then centrifuged at 14000 rpm
for 20 minutes. The supernatant was discarded, and the pellet was
resuspended in 1 ml of sterile distilled water, vortexed, and then
centrifuged again at 14000 rpm for 20 minutes. After
centrifugation, 5 ml of acetonitrile (AN) and 5 ml of 20%
trifluoroacetic (TFA) acid were mixed, added to the pellet and
incubated for 15 minutes at room temperature. After a short
centrifugation at 14000 rpm for 2 minutes, 2 ml of supernatant was
spotted onto a MALDI-TOF MTP 384 target plate (Bruker
Daltonik GmbH, Leipzig, Germany). Four such deposits were
made for each isolate. The preparation was overlaid with 2 mLo f
matrix solution [saturated solution of a-HCCA (alpha-cyano-4-
hydroxycinnamic acid) in 50% AN and 2.5% TFA]. The matrix-
sample was crystallised by air drying at room temperature for 5
minutes.
Protocol 2. Positive blood culture broth (1 ml) was
centrifuged at 500 rpm for 5 minutes in order to remove red
blood cells. The supernatant was then centrifuged at 14000 rpm
for 5 minutes. The supernatant was discarded, and the pellet was
resuspended in 1 ml of sterile distilled, water, vortexed, and then
centrifuged again at 14000 rpm for 5 minutes. After
centrifugation, 5 ml of formic acid was added to the pellet and
incubated for 5 minutes at room temperature. Then, 5 mlo f
acetonitrile was added, and after vortexing and centrifugation at
14000 rpm for 2 minutes, 2 ml of supernatant was deposited on a
MALDI-TOF target plate and processed as described above.
Mass Spectrometry
Measurements were performed with an Autoflex II mass
spectrometer (Bruker Daltonik) equipped with a 337-nm nitrogen
laser. Spectra were recorded in the positive linear mode (delay:
170 ns; ion source: 1; (IS1) voltage: 20 kV; ion source 2 (IS2)
voltage: 18.5 kV; lens voltage: 7 kV; mass range: 2 kDa to
20 kDa). Each spectrum was obtained after 675 shots in automatic
mode at a variable laser power, and the acquisition time ranged
from 30–60 seconds per spot. Data were automatically acquired
using AutoXecute acquisition control software. The spectra of the
four spots for each isolate were imported into BioTyper
TM version
2.0 software (Bruker Daltonik GmbH) and analysed by standard
pattern matching (with default parameter settings) against the
spectra of 2,881 species used as references in the BioTyper
TM
database (these spectra are an integrated part of the BioTyper
TM
software version, as updated in June 2008). The method of
identification included the mass to charge ratio (m/z) from 3 to
15 kDa. For each spectrum, no more than 100 peaks were taken
into account, and these peaks were compared with peaks in the
database. The 15 bacterial species exhibiting the most similar
peptide pattern with the isolate were ranked by their identification
score.
Criteria for Identification of Isolates
For MALDI-TOF analysis, we adapted the score values
proposed by Sengh et al.: an isolate was considered correctly
identified by MALDI-TOF when $2/4 spectra had a score $1.9
or 4/4 had a score $1.2.
Results
Positive Blood Culture Bottles
During the study period, 599 blood culture bottles correspond-
ing to 559 patients were tested. Among these, 15 led to the
MALDI-TOF MS for Bacteremia
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phenotypic or MALDI-TOF mass spectrometry on colonies; they
were thus not considered for analysis. Among the 584 remaining
positive blood cultures, 22 grew more than one species and the
other 562 grew a single species.
Concordant MALDI-TOF Identification (Table 1)
During the period of protocol 1, 322 positive blood culture
bottles were analysed over a five-month period. Among these,
59% yielded identical identification to routine phenotypic tests at
the species level. There was a clear difference between Gram-
positive and Gram-negative bacteria, as 94% of Gram-negative
bacteria were identified, whereas only 37% of Gram-positive
bacteria were identified. Among these, Streptococcus sp. were poorly
identified (4/25, 16%). Protocol 2, which was tested during three
additional months, clearly improved the results of identification.
For Gram-negative bacteria, the results were comparable or
slightly worse to protocol 1, but for Gram-positives, this protocol
significantly improved identification, with 67% identification. This
improvement was mostly effective for Staphylococcus sp., as
Streptococcus sp. remained poorly identified (4/17, 23%). For most
of the represented Gram-positive species, protocol 2 also improved
the mean best score obtained, as it increased from 1.43 and 1.49 to
2 and 2 for S. aureus and Staphylococcus epidermidis, respectively
(Table 1).
Erroneous MALDI-TOF Identification
Only one isolate in one blood culture sample growing a unique
species prepared with protocol 1 and growing Serratia marcescens was
misidentified as Aeromonas hydrophila, with 2/4 positive spots and a
score .1.9. The major cause of erroneous identification was the
presence of two or more species in the same bottle. A mixture of
species occurred in 22 blood culture bottles (Table 2). For two of
these samples, no identification was obtained. For 18 samples, only
one of the two isolates was identified. In the two remaining cases,
including one with three different species in the mixture, MS
identification was erroneous.
Discussion
Many studies have demonstrated that rapid antimicrobial
therapy adapted to the susceptibility of bacteria responsible for
bloodstream infections can reduce morbidity and mortality [20–
23]. In this study, we tested 599 blood culture bottles identified as
culture positive by our Bactec 9240 automate. The efficiency of
mass spectrometry to identify crude bacteria was first established
in non-medical microbiology laboratories [24] and was recently
confirmed as the most promising technique for routine bacterial
identification in clinical microbiology laboratories [19,25,26]. In
the present study, two different protocols for blood culture broth
preparation before MS were tested. The first protocol using TFA
had been reported to be efficient on bacterial colonies [19],;
however, it lacked efficiency for Gram-positive bacteria in blood
culture broth (37% positive identification), whereas it allowed the
identification of 94% of Gram-negative bacteria. By using formic
acid instead of TFA (protocol 2), the identification of Gram-
positive bacteria increased to 67% positive identification, and it
remained high for Gram-negatives, with 88% positive identifica-
tion. Moreover, for the identified Gram–positive bacteria, better
scores were obtained with this protocol, as the mean best score for
S. aureus and S. epidermidis was 2 (data not shown). In fact, a
weakness of MS identification of bacteria from positive blood
cultures was observed with viridans streptococci, which were not
identified at all. This slight loss in efficiency of protocol 2 was
mostly due to negative results observed in four blood culture
bottles containing Ochrobactrum anthropi (Table 1).
In direct testing, we experienced only three false positive results,
for a positive predictive value of 99.2%. In two of the three cases,
the false positive result was due to mixtures of two and three
different species in the same bottle. For the other mixtures of
bacteria, identification was correct, but only one of two species was
identified, even by testing four spots (Table 2). Moreover, it was
impossible to predict what the species identified in the mixture
would be. For example, for the three mixtures containing both
Enterococcus faecalis and Escherichia coli, E. coli was identified in two
cases but E. faecalis was identified in only one. This result means
that Gram staining of blood culture broths after detection by the
automate cannot be omitted, as Sengh et al. proposed in the case
of colonies [19].
Results of the identification by MALDI-TOF MS may be
obtained approximately two hours after the automate has detected
it to be positive. Without automation of the procedure, it would
not be possible to perform sample preparation for MS each time a
blood culture is detected positive by the automate; however, the
procedure may be repeated several times a day, i.e., three times a
day in our laboratory currently. As shown in Figure 1, our
procedure provides identification results 48 h sooner than the
conventional procedure. Moreover, by obtaining quick identifica-
tion, it is possible to perform direct antimicrobial susceptibility
testing by using blood culture bottle broth. This technique has
been demonstrated to be efficient for antibiotic susceptibility
testing with both manual and automated systems, provided that
the inoculums are well calibrated [27–30]. With such procedures,
blood culture again becomes the sample of choice upon admission
of febrile patients to the emergency department. This procedure
requires more identification time than direct detection in blood
using a real-time PCR system as it require bacterial growth in
blood culture bottle before identification [4,5], but it allows
antibiotic susceptibility testing. For quick detection of resistance to
key antibiotics, it is also possible to combine MS-based
identification with molecular-based antibiotic resistance predic-
tion, such as the Cepheid Xpert MRSA/SA blood culture assay,
which allows detection of MRSA and S. aureus in blood culture
bottles detected positive by the automate [16]. This test was
demonstrated to have a sensitivity of 98.3% for detection of
MRSA in blood culture bottles. From our point of view, the major
drawback of Cepheid technique is the cost for the unitary test, as it
has to be performed on all blood culture bottles in which clusters
of Gram-positive cocci are detected, whereas most of these Gram-
positive cocci are coagulase-negative staphylococci, as shown in
our study (191/262, 73%). The association of MS identification on
blood culture bottles followed by Cepheid Xpert MRSA/SA blood
culture assay on S. aureus growing in blood culture bottles is
currently being evaluated in our laboratory with promising results.
On the other hand, in a previous study on S. aureus using MALDI-
TOF, it was observed that MRSA spectral profiles were different
from methicillin-susceptible S. aureus [31]. Detection of beta-
lactamase was also possible with ampicillin-resistant E. coli [32].
However, as signature peaks may shift according to experimental
conditions [32], it will probably be necessary to construct a specific
database of susceptible and resistant organisms growing in blood
culture bottles in order to use MS profiles for antibiotic
susceptibility prediction.
In the present study, the prospectively gathered data demon-
strated that MALDI-TOF identification of bacteria present in
blood culture bottles previously identified as positive by an
automate is an efficient method for the rapid and routine
identification of bacterial isolates in the clinical microbiology
MALDI-TOF MS for Bacteremia
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identification on 599 monomicrobial positive blood culture bottles tested.
Species Protocol 1 Protocol 2
Tested (n=) Identified (%) Mean best score Tested (n=) Identified (%) Mean best score p*
Gram-negative
Escherichia coli 71 68 (96%) 2.02 34 31 (94%) 2.1
Klebsiella pneumoniae 10 9 (90%) 2.05 18 17 (94%) 1.9
Klebsiella oxytoca 4 4 (100%) 3 3 (100%)
Raoultella planticola 1 1 (100%)
Raoultella ornithinolytica 0 1 1 (100%)
Enterobacter aerogenes 2 2 (100%) 10 8 (80%)
Enterobacter cloacae 4 4 (100%) 9 7 (77%)
Serratia marcescens 3 3 (100%) 5 4 (80%)
Morganella morganii 1 1 (100%) 1 1 (100%)
Citrobacter koseri 2 2 (100%) 2 2 (100%)
Proteus mirabilis 0 4 4 (100%)
Pantoea agglomerans 1 0 (0%)
Salmonella enterica 3 2 (66%) 0
Pseudomonas aeruginosa 12 12 (100%) 2.26 3 3 (100%)
Acinetobacter baumannii 2 1 (50%) 0
Pseudomonas fluorescens 0 0 (0%) 0
Stenotrophomonas maltophilia 0 1 1 (100%)
Haemophilus influenzae 2 0 (0%) 1 1 (100%)
Haemophilus parainfluenzae 2 2 (100%) 0
Neisseria meningitidis 2 1 (50%) 0
Aeromonas hydrophila 0 1 1 (100%)
Achromobacter ruhlandi 0 1 1 (100%)
Ochrobactrum anthropi 0 4 0 (0%)
Bacteroides fragilis 3 3 (100%) 0
Bacteroides ovatus 1 1 (100%)
Bacteroides vulgatus 1 1 (100%)
Gram-negative 125 117 (94%) 100 87 (87%) 0.09 NS
Gram-positive
Staphylococcus aureus 50 20 (40%) 1.43 21 15 (58%) 2
Staphylococcus epidermidis 59 19 (32%) 1.49 71 57 (80%) 2
Staphylococcus hominis 16 9 (56%) 8 6 (75%)
Staphylococcus warneri 9 2 (22%) 1 1 (100%)
Staphylococcus haemolyticus 6 3 (50%) 4 1 (25%)
Staphylococcus xylosus 1 0 (0%) 0
Staphylococcus lugdunensis 2 1 (50%) 0
Staphylococcus capitis 5 3 (60%) 3 2 (33%)
Staphylococcus caprae 1 0 (0%) 0
Staphylococcus cohnii 2 1 (50) 0
Staphylococcus saprophyticus 1 0 (0%) 1 0 (0%)
Micrococcus sp. 4 0 (0%) 2 1 (50%)
Enterococcus faecalis 10 9 (90%) 5 3 (60%)
Enterococcus faecium 3 1 (33%) 4 3 (75%)
Streptococcus pneumoniae 9 3 (33%) 3 2 (66%)
Streptococcus pyogenes 2 1 (50%) 1 1 (100%)
Streptococcus sanguis 2 0 (0%) 0
MALDI-TOF MS for Bacteremia
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identification of bacteria in blood cultures, but it currently presents
two major pitfalls. First, in the case of a mixture of species, only
one is identified, and false identification can occur. This means
that Gram staining of blood culture broth must be done in all
cases. The second is that it does not allow identification of viridans
streptococci. As such identification is possible from colonies
growing on agar, it is likely that improvement in the preparation
of bacteria before deposit could rectify this shortcoming.
Species Protocol 1 Protocol 2
Tested (n=) Identified (%) Mean best score Tested (n=) Identified (%) Mean best score p*
Streptococcus intermedius 1 0 (0%) 0
Streptococcus agalactiae 3 0 (0%) 1 1 (100%)
Streptococcus mitis 3 0 (0%) 2 0 (0%)
Streptococcus salivarius 2 0 (0%) 0
Streptococcus anginosus 3 0 (0%) 0
Streptococcus constellatus 0 3 0 (0%)
Streptococcus oralis 0 2 0 (0%)
Streptococcus haemolyticus 0 1 0 (0%)
Streptococcus gallolyticus 0 4 0 (0%)
Gemella morbillorum 1 0 (0%) 0
Corynebacterium jeikeium 1 0 (0%)
Corynebacterium ulcerans 1 0 (0%)
Corynebacterium sp. 0 2 0 (0%)
Bacillus cereus 0 1 1 (100%)
Gram-positive 197 72 (37%) 140 94 (67%) ,10
22





Table 2. The results of MS identification of the 22 blood
culture bottles containing two different species (* mixture of
species resulting in false positive results).
Species 1 Species 2 MS identification
E. coli S. epidermidis E. coli
E. faecalis E. coli
E. faecalis E. coli
K. pneumoniae E. coli
P. mirabilis E. coli
E. faecalis E. faecalis
A. baumannii A. baumannii
S. pneumoniae S. pneumoniae
S. epidermidis S. marcescens S. aureus*
S. haemolyticus S. haemolyticus
S. haemolyticus S. epidermidis
E. faecalis E. faecalis
S. aureus S. epidermidis
P. aeruginosa E. faecalis E. faecalis
S. aureus S. aureus
B. fragilis B. fragilis
E. faecalis S. hominis E. faecalis
K. pneumoniae + A. sobria A. culicicola*
E. cloacae E. faecium E. cloacae
S. aureus No identification
S. aureus P. avidum No identification
M. morganii S. pneumoniae M. morganii
doi:10.1371/journal.pone.0008041.t002
Figure 1. MALDI-TOF identification. Proposed MALDI-TOF MS
procedure for identification and antibiotic susceptibility testing of
bacteria isolated from blood culture and comparison of conventional
procedure. The data obtained in the present study are indicated in
parentheses.
doi:10.1371/journal.pone.0008041.g001
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